SLI
2.005,89
PKT
-2,63
PKT
-0,13
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.11.19 | Novartis Neutral | UBS AG | |
| 25.11.19 | Roche buy | UBS AG | |
| 25.11.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 25.11.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 25.11.19 | Novartis buy | Jefferies & Company Inc. | |
| 25.11.19 | Roche buy | Deutsche Bank AG | |
| 25.11.19 | Roche overweight | JP Morgan Chase & Co. | |
| 22.11.19 | UBS Sector Perform | RBC Capital Markets | |
| 22.11.19 | UBS Sector Perform | RBC Capital Markets | |
| 20.11.19 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 18.11.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 18.11.19 | ams-OSRAM buy | Kepler Cheuvreux | |
| 15.11.19 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 15.11.19 | Zurich Insurance Hold | Deutsche Bank AG | |
| 15.11.19 | Zurich Insurance Hold | Kepler Cheuvreux | |
| 15.11.19 | Zurich Insurance Neutral | UBS AG | |
| 15.11.19 | ABB (Asea Brown Boveri) buy | HSBC | |
| 14.11.19 | Zurich Insurance Neutral | UBS AG | |
| 14.11.19 | Givaudan Neutral | UBS AG | |
| 14.11.19 | Roche buy | UBS AG | |
| 14.11.19 | UBS buy | Goldman Sachs Group Inc. | |
| 14.11.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 13.11.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 11.11.19 | Roche buy | UBS AG | |
| 11.11.19 | Roche Neutral | Credit Suisse Group | |
| 11.11.19 | Roche buy | Goldman Sachs Group Inc. | |
| 08.11.19 | Zurich Insurance Hold | Deutsche Bank AG | |
| 07.11.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 07.11.19 | Zurich Insurance Outperform | RBC Capital Markets | |
| 07.11.19 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 07.11.19 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 07.11.19 | Roche buy | UBS AG | |
| 06.11.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 06.11.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 04.11.19 | Holcim overweight | Morgan Stanley | |
| 04.11.19 | UBS buy | Goldman Sachs Group Inc. | |
| 04.11.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 01.11.19 | Swiss Re Sell | UBS AG | |
| 01.11.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 01.11.19 | Swiss Re Sector Perform | RBC Capital Markets |